Inventor · disambiguated record
Laurence Bessac
Also filed as: BESSAC LAURENCE
7 granted patents·14 pending applications·57 citations·filing 2012–2024
86Inventor score
Top patents by PatentIndex Score
21 records- 0193US9561155B2Method of reducing cholesterol levels using a human anti-PCSK9 antibodyHANOTIN CORINNE·Filed 2012·Granted Feb 7, 2017·18 cites·25 claims
- 0292US11246925B2Human antibodies to PCSK9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2019·Granted Feb 15, 2022·5 cites·13 claims
- 0391US12083176B2Human antibodies to PCSK9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2021·Granted Sep 10, 2024·1 cites·10 claims
- 0491US11306155B2Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibodySANOFI BIOTECHNOLOGY·Filed 2019·Granted Apr 19, 2022·5 cites·14 claims
- 0591US9682013B2Pharmaceutical compositions comprising human antibodies to PCSK9HANOTIN CORINNE·Filed 2012·Granted Jun 20, 2017·11 cites·15 claims
- 0688US10544232B2Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibodySANOFI BIOTECHNOLOGY·Filed 2015·Granted Jan 28, 2020·9 cites·16 claims
- 0787US2025064926A1Human antibodies to pcsk9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 0884US10428157B2Dosing regimens for use with PCSK9 inhibitorsSANOFI BIOTECHNOLOGY·Filed 2014·Granted Oct 1, 2019·8 cites·13 claims
- 0982US2025059300A1METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODYSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 1073US2022315669A1METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODYSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 1167US2017340515A1Pharmaceutical compositions comprising human antibodies to pcsk9SANOFI BIOTECHNOLOGY·Filed 2017·Application pending·0 cites
- 1262US2020255544A1Methods for treating high cardiovascular risk patients with hypercholesterolemiaSANOFI BIOTECHNOLOGY·Filed 2019·Application pending·0 cites
- 1361US2022144969A1Methods for reducing cardiovascular riskSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 1460US2017266079A1Human antibodies to pcsk9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2016·Application pending·0 cites
- 1553US2018296672A1Methods for Treating Patients with Hypercholesterolemia that is not Adequately Controlled by Moderate-Dose Statin TherapyREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 1650US2020024364A1Dosing regimens for use with pcsk9 inhibitorsSANOFI BIOTECHNOLOGY·Filed 2019·Application pending·0 cites
- 1749US2015231236A1Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapyREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 1843US2019292273A1Methods for reducing cardiovascular riskSANOFI BIOTECHNOLOGY·Filed 2019·Application pending·0 cites
- 1943US2015140002A1Use of a pcsk9 inhibitor to treat hyperlipidemiaSANOFI SA·Filed 2014·Application pending·0 cites
- 2039US2016137746A1Methods for treating high cardiovascular risk patients with hypercholesterolemiaSANOFI BIOTECHNOLOGY·Filed 2015·Application pending·0 cites
- 2135US2015284473A1Methods for reducing cardiovascular riskBESSAC LAURENCE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurence Bessac files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →